MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations

Recruiting
Conditions
Lyme Disease
First Posted Date
1999-11-04
Last Posted Date
2024-12-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
700
Registration Number
NCT00001539
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

Recruiting
Conditions
ICL
HIV
Healthy Volunteers
First Posted Date
1999-11-04
Last Posted Date
2024-12-17
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
635
Registration Number
NCT00001471
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Syndromes

Recruiting
Conditions
XLA
CVID
First Posted Date
1999-11-04
Last Posted Date
2024-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
500
Registration Number
NCT00001244
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Completed
Conditions
Wegener's Granulomatosis
Vasculitis
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
100
Registration Number
NCT00001473
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Phase 3
Completed
Conditions
Herpes Simplex
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
180
Registration Number
NCT00001649
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Phase 4
Recruiting
Conditions
Toxoplasmosis
Interventions
First Posted Date
1999-10-19
Last Posted Date
2009-05-14
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
600
Registration Number
NCT00004317
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath